arrow
A

Allison P. Wheeler

university of washington school of medicine
H指数:21
被引数:2,371

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FRONTIER5: Safety and patient experience of a direct switch from emicizumab to denecimig (Mim8) in patients with haemophilia A with or without inhibitors

FRONTIER5:从emicizumab直接转换为denecimig(Mim8)在有无抑制剂的血友病A患者中的安全性与患者体验

2026-09-120
OAAI
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial
2024-12-011
PRE
A Phase Ia Study of VGA039, a Protein S-Targeting Monoclonal Antibody, in Individuals with Von Willebrand Disease Demonstrates Concentration-Dependent Increases in Thrombin Generation for Reducing Bleeding

一项关于VGA039(一种靶向蛋白S的单克隆抗体)在冯·维勒布兰德病患者中的Phase Ia研究,表明其可通过浓度依赖性增加凝血酶生成来减少出血。

BLOOD
IF23.1
2024-11-050
PRE
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodes
2024-08-131
OAAI
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components

减少病原体和常规血小板成分支持的血液病患者的急性肺损伤

2024-05-140
OAAI